Seven Bridge Financial Group, LLC Biogen Inc. Transaction History

Seven Bridge Financial Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 09, 2019	SELL	$217.44 - $243.88 $73,277 - $82,187	-337 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $3,684 - $5,762	-17 Reduced 4.8%	337 $80,000
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $55,366 - $65,985	-215 Reduced 37.79%	354 $103,000
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $5,202 - $7,358	-20 Reduced 3.4%	569 $156,000
Q4 2017 Feb 20, 2018	SELL	$307.64 - $344.58 $76,294 - $85,455	-248 Reduced 29.63%	589 $188,000
Q3 2017 Nov 13, 2017	SELL	$281.15 - $329.69 $11,808 - $13,846	-42 Reduced 4.78%	837 $262,000
Q2 2017 Aug 14, 2017	BUY	N/A	879	879 $239,000

1,050

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Seven Bridge Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Seven Bridge Financial Group, LLC with notifications on news.